Preliminary safety and efficacy of GX-I7, a long-acting interleukin-7, in combination with pembrolizumab in patients with refractory or recurrent metastatic triple negative breast cancer (mTNBC): Dose escalation period of Phase Ib/II study (KEYNOTE-899).
暂无分享,去创建一个
Sung-Bae Kim | Y. Im | N. Le | Y. Sung | J. Sohn | K. Park | J. Kim | H. Ahn | K. Lee | K. Lee | J. Woo | Minkyu Heo | Ji-Won Kim | Jee Hung Kim | Se‐Hwan Yang